Current Status and Advancements in Platelet-Rich Plasma Therapy.
| Autor: | Pretorius J; Trauma and Orthopaedics, University Hospital Galway, Galway, IRL., Habash M; Orthopaedics and Traumatology, University Hospital Galway, Galway, IRL., Ghobrial B; Trauma and Orthopaedics, University Hospital Galway, Galway, IRL., Alnajjar R; Trauma and Orthopaedics, University Hospital Galway, Galway, IRL., Ellanti P; Trauma and Orthopaedics, Letterkenny University Hospital, Letterkenny, IRL. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Oct 17; Vol. 15 (10), pp. e47176. Date of Electronic Publication: 2023 Oct 17 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.47176 |
| Abstrakt: | Platelet-rich plasma (PRP) as a treatment modality has been around for the last four decades, but only truly gained popularity over the last 10 to 15 years in medicine, in a variety of fields ranging from regenerative medicine to infertility treatment. It has gained popularity, especially in treating musculoskeletal conditions where the bulk of research has been performed and published. There is level I evidence available supporting its efficacy in the treatment of osteoarthritis (OA), epicondylitis, bursitis, compressive neuropathy, plantar fasciitis, muscular injuries and osteochondral lesions. Most published research with regards to PRP has been focused on knee OA (limited research in shoulder, elbow, and foot and ankle OA), lateral epicondylitis and carpal tunnel syndrome, whereas spinal and hand conditions have limited research available. Tendinopathies and partial tendon tears have conflicting evidence available, with level I evidence supporting PRP's use in rotator cuff tendinopathies and tears, with contradictory level I evidence discouraging its use in patella and Achilles tendinopathies and tears. The available evidence regarding the use of PRP continues to produce conflicting results, but despite this, there is an ongoing increase in the popularity and use of PRP in patients with musculoskeletal conditions. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Pretorius et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|